Combination Therapy of 5-Fluorouracil with Rapamycin for Hormone Receptor-negative Human Breast Cancer

(1)

Title

Combination Therapy of 5-Fluorouracil with Rapamycin for

Hormone Receptor-negative Human Breast Cancer( 内容の要旨

(Summary) )

Author(s)

細野, 芳樹

Report No.(Doctoral

Degree)

博士(医学) 乙第1448号

Issue Date

2010-11-17

Type

博士論文

Version

none

URL

http://hdl.handle.net/20.500.12099/36537

※この資料の著作権は、各資料の著者・学協会・出版社等に帰属します。

(2)

ft Y. (-1=i.J[..I-)

'1i;1(_1'r_a) T!rI-_lil

Jlit(;.(;ll ij-.fii-l-'7':(il(_llt-tj.[l(.-ll

I:-/:(itLll.ij.:_LA!l.(!f:

I:_;:'1_{(iJ/-_.;-I;iT}_{1- liEi}_I;I

S- 4f 45;Jf_fl aq 2f 5f 61 (I.i==.)JILT[TJ 1,jFi _(BiJBS) zlhihN 1 448 % TiFik 22 iF ll j] 17 E] i-I;{=IiuR,Fun4 51Z%tm2 r/Fi-6h-'j

Combination Therapy _of 5-FLuorouracil _with Rapamycin for Hormone Receptor-negative Human Breast Cancer

(j=4f) _1kklJj2I);J: Fyi

(I-.';rJ4f)_1%'jZ. 1-/( +''r hli 3c &li4 IF _]% i a

;a5tPq*0)fB

[#=]

SL#n*fB*FRq5Et&8j:a.b 1 _7f^8=if- L, 4te-i<Jrd:_jE/&U).iu'l-Jrf1!JJLrt1),1i:rC.J&-i'_-fJkL(1bi t3:1 flo * rCli

*}v%y (IR I,t=_Fly) _f%*t4=R%Jr&, HER2 _{,3%*[1{(Epidcrmill} Growth Factor _{rcccptor2)FE,.JrkSL#Tb'}

.'Tia',.:.J2 0 i).:,,+Irid-L'!), -f1?r']'J(I:ui..r'LIA:)I)I;i::)-/(I,f}1-1{l'iTt;'1;)

i), I[[!I(2,1'.:F'(I;'iJ1:I;:.r')'Ji L -/i)JLt1'-1:lT!('l9tiT'J..))'.(i!TE1 (I I.}u 11t11t.LIE,1J_{77-i+-.J[-;J3i}S < , A;i)I,i-:a)l3tJ-I,i--L':..'iJ<J-I.L7:=*tl':tiiJiL

-i, _LI_a, _)'J

,.t.-)_,i.Lll3l:):.,+i-iHILJL,ri.lflrL:=}7,tf:L

##mB&#8=xlJL, Eg#3ASAJO) key drug i 5YLa 5FU i , %U)11=)tl7;r,l1.T),3itl)-73f=d)a)mTOR PRS#].

Rapamycin kI#j3]+ 8 fb**P&k#,jEJ+ L4*51 LT=o

[*;'L i md'iE*6r]

I.

.;i':Lu11B1:,'4ei i.:I:.i!'iJ33ll!tl1'E

l) #.PBFii#: t= _I,JAB/*pB&4# SKBR-3 (HER2 a;#g1, =x Ttt= _{F)y52*I*1&#ga)} i:1fj]].

2) fLg*S* : _{loo/.FBS+DMEMJ%%8=T} 37oC, 50/.cO2+950/. air -FTtf-i.ia:i.

2. MTT assay : (0.1-lOmM)5FU *44!#t (0.1-lOmM)5FU L= Rapamycin lOJJM kJlhpL,T=2#k 72 FS

Fpqlff*i&8=MTT assay 8=ct 9 IC50 k#H L,tEFEkL,f=.

3. Apoptosis assay : _chamber _slide treB*i&8=4}ieL2(0. 1-10mM)5FU i RapamycinlOFLM *hDia 24

FSPRq8=T Hoechst 33342 _-C>%&, #jt*/j&qfRvC>&#51 L,flo

4. Westernblotting :4}#BE(0. _l-lOmM)5FU i RapamycinlOp M.#hn, Lift:/t&8=RIPAbuffer _rC>*AS,

iETRf7*&/t&8= PVDF BS-0) transfer kWEt=T, _{-yj:btI*(mTOR,} ERR, ART, _p70S6K, _caspase3,

cyclineBl, TS, OPRT), =yj:rnI4=n)fTyq8=blotting L,f=.

[#A]

l. Rapamycin 8=i 9 DNA %Bk8=b'V'TB;5St3:##Thb 9 , A,-3 5FU 0)##u]&rnJr&8=75,A,ba TS

(Thymidylate Synthase) a)ieLiJ&rfJrfEfEJr&1if:fbS*6nf=. _-jf 5FU _{a)1t-dJ##rehb} 9 RNA %BkPR $8=Bel%+8 0PRT (Orotate Phosphoribosyl Transferase) Ej:'2elELjib,J3 f=.

3: f= _cyclin Bl _0)#gaEj: Rapamycin 0)ieL5i&#.r&8=tm& L,TU _lf=.

2. Rapamycin 8=ct D _{ERR(Extracellular} Signal-regulated _Kinase) i ART 0) u _{y#1EbS#fRLf=.}

bt&hlE#Hcatalase) *ilP8=i 9 ERR U _y#1EEj:nS[J Snf=bS ART _Ej:W$lJ5a17bA'-3f=o 3:f= ERR

PFIJ.Af-,:;7ulu

ET(I(i) >LL:1-flf(i:_{,lfJli]:fill-)-}e}r, _IIKT !)> n--L'f(i:(ILq[J['lJ-I)L _/ill_7).-T'7=

3. 5FU *iA8=tE L,T 5FU i Rapamycin i 0)I#j7]8=T, ieLEJ&#Jr&8=#tPB&tB#bSWSIJ5hf=. 3:f= IC50

8j:5FU *i&(5. lj=0. 2 _mM)8=tE L,T Rapamycin iqShp#(o. 25j=0. 03 _{mM) tj:#%8=} _{(p4. 004)1ff:1#pC>b}

I?flo

(3)

-69-4. Apoptosis _assay vCtEj:, 5FU qi4d!C=L-EL,Rapamycin I3FJm=ct 9 _apoptosis AS 2. _9L%f9hD+8 I tbS

7iJ(E-7iet5nf=(^popticIndex : 0. 018 vs 0. _053). Rapamaycin ilfiW.T.Ej:_caspase-3 _{0)7EJr&1Ek;;Ehb}

tLL>fpJ3flo L,fp L,5FU i f(apamycin fJl)i..m1-7L)i 5r.'Uili4d]"iV)_1tkf2]'iJit-_{(lmM i=W} _L/C 0._1mM)vC. caspasc3 A'it7-FfJrgilE:L, f=.

[%*]

5FU _{Eiri;-T)r-i.1[i'J'(=Mi)fl}_cT5itrC U,7J /)1;

, 7i1_4dirC.EiI0 -30'yotrJiL=U);!j$5y]*re.AV)/3)uX-fJllt1.J'&+a ##Jo)19i

;}(?;uS!='j',:Si tJ:I? TU '7uo _-)I I(air)ZlmyCin Ej:-/// tj 9 / I,ll,i?,.T)i/J=4hfJJfn-Wire.A9 , #tru)]}dPq.J9>l+/i,lii

ijf,q!,.retCiPl3K-^KT a.)_{1=tfiC=LiA/:ill._TrL.}L;I:[I7)J'dll.lJl)^I-ttLtiflc=[i!.Jb7D

mTOR krSAELLf{+ao 75,i 5 tJ:} A I XJ> _&fE

7))L,, mTOR rSA:.i;:371Jtj:ritf;'.lI7]1Jd1!:L'J'C=*.).L T _{[Lii.I)iJ.i:JH}a it a tLL>_t'1fRri.aE] 5 YLT U,_a _Ri#J_a)--3rC=,A _8.

4.Eq*.1.J{Ai L,_{7tg'Llh-a:[Il)JJd1:Ait=}Ej: IILm2 _{,3Z:#[1</utr[.:.ijEfR}L, T U1_{8 75;, i}

0)fWL-elj: PI3K-^KT {iR_75SiE3ERti B]1- i LT.)9h1+/i,IZiii;.#,∼C=[y..Jlj--L/C U∼7u _I _i _7h ₆

, mTOR 0)PRf5ilaA8=m4S L/C4.BgO)lGTg'1i:-;=i-W

L,f=.

4tEgO)jS.ei&re.Ej:,Rapamycin L=(i V) 5[.1U_{a)ffTy,.if,n.i:E)bn--3T>b8}TS bS#'j)1+8 I i k6&JiEhL,f=. ct 9 _{a; I//i/v7h#ga+a} TS Ej:5FU C=*.[l)-7u.7fTu-(1BIJt.r4:k'it+f=b,5FU _{nlfjEf95&8=Ej:} TS _0)WS-IJbS52

3:L,U'o Rapamycin i _0)l3T-jfH=J:V)a:(IJ)J'dltl')I;n'L';?1;-JlqDIJff;-uSna I i bS*uPj]L,f=. } _*=RILe)ASPB i

L,I, _--38=Ej: Rapamycin _nI3FmC=J: V) 5I;U EiJ: niWIL2vC. _caspase-3 kfEJhlb+a I i kEiEPA Lf=

bS, apoptosis 0)tB5&Ej:apoptosis /JII1=a)ll.Yt))IIC=it;U'T bT'k-iBh5alf=I i _Th#*BbStB L,f=. 5 6 8=,

Rapamycin _0)I#FB8=ct 9 #PBFiJm9JG2/M IUJfJ.J.7Jf!7i-()-736B.cyclinBl _0)#4abSim&+a I i bS*]PA L,

*tTn)JLirL[I]lJ3JU)(.;J:LJti L. I) _{)r.3-et;i-..,I,=ift('J'J}

(='i'M)Jbll.Yl/^t-I:,i(il-lh'lilJ-I)-,=i)I LJ_{7)-I;llI'-:.I:.ii}i:

,1L-/I._.i:n7]7L!IJ1,i,//+/L :I['',:]L -i.

Ej:,Rapamycin Gj:ERR i ART 0) U _{y6*1E:fJ3Ef)i+7D} I i k#=#L,FIBS, ERR. AKT i bA=*Ej:,*PB&nfB

z^n[T;..[[:_:=ly.-Jh--Tr_{,3 rJ(1-}(--Lr:tLi-r)}5I _LL.;Jt;_{fLt:-)1;-a)1Zit/it}i..'j:1tI]il)-,TJrJIJ.ni,}Tt(i',)-) _{-j=._.}L 7h L rlRK iiT.-.ri(i:.'ii-;tr5*

1E#Hcatalase) 8=ct D _5%4%8=WSu 5n7t= i i , Et(K PREL=#JrClj:AKT U y&1EkWSTJ L,ktj:A,J3f=.

L,T=ASJ3T, ERR a) U _{y&hlkEj:&1t:A} T,I/A _C=ct _aEiFSre.A _{9.>9h'+)i,fEJEE8=Ej:#5ilarcht3:V'q6EJr&8=}

hpk, AKT Ej: ERR _{f.#Tltj:t3:< 4&5i} L,T=bo)rC.ba I i ASfC#5nf=o tf3b'ART U _{>&Jb8=-3V'TEj:,}

mTOR kf#Bk+8 TORC2 b1 6 AKT I-tn 7 _-I

-rI/iy 9 a;FEifB8o)Hj14Ttk#,jar+,L,Th' 9%i&o)1*ilbSiE'fvehb

a.

[S=;&]

Rapamycin tj:, _{-h%BW=tB#fEJr&bSSu} '*)i,f> (=R h t= _Fly) _5%26t4=P%r&. HER2 _{5E2gfI4=BBJEESL}

*l*PB5]ei8=jb'V'T TS _k.b#'j)'5if, _apoptosis _0)3ega.

/SmB5]EitB#9--/9 )I,0)iSJtkAt L,T 5FU a)5ilaAk i

i)_{1ll',J.3a;/)-}I)}I

LL ,i-;(IiR)i_LT>-.-tL1-II i /-')i

i-3 , {>1'2u)I:U[.i-tifJ.1].i:=J31+ 7J_{a;i.r,i![LJT]JJ_)} ,F]ii?I);7TJ,t')lLtL,,-)I i =lt; ,q1$5Yt/flo ;&3c%i5o)#=AO)fEf

*i#% #P]W#1gGj:, t= _{f,vG#LfB-#mB&4#kJnlT,} Rapamycin I#jm=i 9 5FU

a)##U3aF7LJr&8=FxlSi-8 TS k#'j>5it, 5 68= _apoptosis 0)#fR. #PB&tB*+/ 9}L,0)1SAk*L,T 5FU _{a),}l*Aktm&-f8} I _{i 'i-.i'n7_F7)I}L f=.: 1LLL:I.i i.)

-4=nFTE.'i.)JqiJ.!Jpl:9H.-=L;i.'J_LliBUlt:I, _{]1.).Lt:I;[t:I:-F:T!.(tiifU)}5t:i)i.i-;I_'j)jL.;r),

tBT3i:i'.tf!f

-f8 bo)t5%kE)n8.

[-jI.;I:iii'/1t-]i-.-i-.i-:J

YOSHIKI HOSONO, SHINJI OSADA, MASAHITO NAWA, TAKAO TAKAHASHI, KAZUYA YAMAGUCHI, YOSHIHIRO

KAWAGUCHI _and KAZUHIRO YOSHIDA : Combination Therapy _of 5-Fluorouracil _with Rapamycin

for Hormone Receptornegative Human Breast Cancer

Anticancer Research 30, 2625-2630 (2010)